Partner, Global Enterprise Risk Services Finance Transformation Leader
Andy is the lead partner for Life Sciences in Deloitte’s Information & Technology Risk group. Andy’s experience includes controls advisory, regulatory compliance, IT internal audit, digital governance, technology due diligence and ERP controls.
He has sixteen years experience helping clients in the corporate sector manage the risks associated with the use of emerging technologies and existing systems. His current clients include AstraZeneca and Novartis.